Aspirin on par with dalteparin in preventing VTE after hip replacement

06/4/2013 | Medscape (free registration)

Aspirin performed comparably to dalteparin in preventing venous thromboembolism following total hip arthroplasty, according to a 778-patient study in the Annals of Internal Medicine. There were no major bleeding events in the group given aspirin, while there was one case in the dalteparin group. Clinically significant nonmajor bleeding and minor bleeding were reported more often in the dalteparin group than the aspirin group.

View Full Article in:

Medscape (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA